CRISPR Therapeutics AG - Common Shares (CRSP)
42.18
-1.16 (-2.68%)
Crispr Therapeutics is a biopharmaceutical company that focuses on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing technology
The company aims to harness the potential of genetic editing to treat various conditions, including genetic disorders, cancer, and autoimmune diseases. Through a combination of innovative research and strategic collaborations, Crispr Therapeutics is dedicated to advancing its pipeline of therapies and ultimately improving patient outcomes and quality of life.
| Previous Close | 43.34 |
|---|---|
| Open | 42.93 |
| Bid | 42.17 |
| Ask | 42.30 |
| Day's Range | 40.82 - 43.34 |
| 52 Week Range | 36.52 - 79.33 |
| Volume | 1,200,677 |
| Market Cap | 3.33B |
| PE Ratio (TTM) | -9.697 |
| EPS (TTM) | -4.4 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 2,687,842 |
